Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Biomarkers in Tears May Help Diagnose Parkinson’s Disease

Publish date:: May 14, 2019

Key clinical point: Noninvasive measurement of biomarkers in tears may help to diagnose Parkinson’s disease.

Major finding: The amount of oligomeric alpha synuclein was almost five times higher in patients than in controls.

Study details: A prospective collection of reflex tears from 165 patients with and without Parkinson’s disease.

Disclosures: Dr. Lew reported receiving research support from the Parkinson’s Study Group, the Michael J. Fox Foundation, Biotie Therapies, NeuroDerm, Enterin, Pharm2B Fellowship Grants, Allergan, and Medtronic.

Citation:

Lew M et al. AAN 2019, Abstract S10.001.

This Week's Must Reads

Cardiac Arrhythmia Heightens Mortality Risk During Epilepsy Hospitalizations,

High Infantile Spasm Risk Should Contraindicate Sodium Channel Blocker Antiepileptics,

Study Delineates Spectrum of Dravet Syndrome Phenotypes,

Bariatric Surgery Tied to Fewer Cerebrovascular Events,

Reduction in convulsive seizure frequency is associated with improved executive function in Dravet syndrome,

Must Reads in Movement Disorders

Parkinson’s patients can lose swimming ability after deep brain stimulation,

Antibiotic use may increase the risk of Parkinson’s disease,

Increased Parkinson’s disease risk seen with bipolar disorder,

Anticholinergic Drugs Linked to Dementia in Older Populations,

CSF Neurofilament Light Level Could Aid in Diagnosis,